APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,805,395 | +40.0% | 173,495 | +1.4% | 0.05% | +35.9% |
| Q1 2023 | $11,286,350 | +49.8% | 171,109 | +17.4% | 0.04% | +44.4% |
| Q4 2022 | $7,534,354 | -62.3% | 145,704 | -50.3% | 0.03% | -30.8% |
| Q3 2022 | $20,010,130 | +182.6% | 292,976 | +87.1% | 0.04% | +200.0% |
| Q2 2022 | $7,081,952 | +35.6% | 156,610 | +89.5% | 0.01% | +62.5% |
| Q2 2021 | $5,222,000 | +173.7% | 82,642 | +85.9% | 0.01% | +33.3% |
| Q1 2021 | $1,908,000 | -84.2% | 44,461 | -78.9% | 0.01% | -84.2% |
| Q4 2020 | $12,075,000 | +111.3% | 211,108 | +11.4% | 0.04% | +81.0% |
| Q3 2020 | $5,715,000 | -48.7% | 189,427 | -44.5% | 0.02% | -4.5% |
| Q2 2020 | $11,146,000 | +29.6% | 341,268 | +6.3% | 0.02% | +4.8% |
| Q1 2020 | $8,600,000 | +48.9% | 320,982 | +70.2% | 0.02% | +75.0% |
| Q4 2019 | $5,774,000 | – | 188,582 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |